A phase II trial of concurrent carboplatin/VP-16 [etoposide] and radiation followed by paclitaxel (Taxol) for poor-risk stage III non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2012
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Jul 2012 Actual end date (1 Dec 2007) added as reported by ClinicalTrials.gov.
- 28 Sep 2005 New trial record.